Post-approval studies (Phase 4)Study completedNCT03406117
What this trial is testing
Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
Who this might be right for
HealthyAtopic DermatitisPsoriasis
Haus Bioceuticals 182